BioSpace News Archive

Bringing Industry Experts Together to Develop New Diagnostic Technology for Deep Space Missions

Walgreens and McLaren Health Care, a fully integrated health network committed to quality, evidence-based patient care and cost efficiency, today announced that they have entered into a strategic collaboration focused on health service and pharmacy offerings.

EDC is pleased to announce it is now in network with Colorado TRICARE insurance, held by most active and retired military and their families, for the treatment of eating disorders.

SCAN Health Plan®, one of the nation’s largest not-for-profit Medicare Advantage plans, has received a 4.5-star rating on a five-point scale for 2019 from the Centers for Medicare and Medicaid Services (CMS) for the second consecutive year.

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that it has submitted a New Drug Application (NDA) to Japan’s Ministry of Health, Labor and Welfare (MHLW) for marketing approval of quizartinib for the treatment of adult patients with relapsed/refractory FLT3-ITD acute myeloid leukemia (AML

Abbvie announced that FDA has accepted its supplemental New Drug Application

Spherix Incorporated (Nasdaq: SPEX) today provided shareholders with a video demonstration on its website of the potential effectiveness of CBM BioPharma, Inc.'s (“CBM) innovative drug platform.

Akero Therapeutics, Inc., a biotechnology company developing transformational treatments for non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases, today announced the appointment of Kitty Yale as chief development officer.

To raise awareness about the health-care industry’s lack of price transparency, the Association of Independent Doctors, a national nonprofit trade association, today released a short video satire called “The Perfect-Money-Making

Ferring will access Evotec’s integrated small molecule discovery and development platform to progress new molecules from concept to potential drug candidates